 | Up a level |
Pericàs, Juan M; Anstee, Quentin M; Augustin, Salvador; Bataller, Ramón; Berzigotti, Annalisa; Ciudin, Andreea; Francque, Sven; Abraldes, Juan G; Hernández-Gea, Virginia; Pons, Mònica; Reiberger, Thomas; Rowe, Ian A; Rydqvist, Peter; Schabel, Elmer; Tacke, Frank; Tsochatzis, Emmanuel A; Genescà, Joan (2024). Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis. (In Press). Nature reviews Springer Nature 10.1038/s41575-024-00976-3
Pericàs, Juan M; Anstee, Quentin M; Augustin, Salvador; Bataller, Ramón; Berzigotti, Annalisa; Ciudin, Andreea; Francque, Sven; Abraldes, Juan G; Hernández-Gea, Virginia; Pons, Mònica; Reiberger, Thomas; Rowe, Ian A; Rydqvist, Peter; Schabel, Elmer; Tacke, Frank; Tsochatzis, Emmanuel A; Genescà, Joan (2024). A roadmap for clinical trials in MASH-related compensated cirrhosis. (In Press). Nature reviews Springer Nature 10.1038/s41575-024-00955-8
Rowe, Ian A; Villanueva, Càndid; Shearer, Jessica E; Torres, Ferran; Albillos, Agustín; Genescà, Joan; Garcia-Pagan, Joan C; Tripathi, Dhiraj; Hayes, Peter C; Bosch, Jaume; Abraldes, Juan G (2023). Quantifying the benefit of non-selective beta-blockers in the prevention of hepatic decompensation: a Bayesian re-analysis of the PREDESCI trial. Hepatology, 78(2), pp. 530-539. Wolters Kluwer 10.1097/HEP.0000000000000342
